Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 27.05
-2.7 %
$ 869 M
Market Cap
14.53
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Collegium Pharmaceutical, Inc.
| Net Income | 69.2 M |
| Depreciation & Amortization | 169 M |
| Capital Expenditures | -1.65 M |
| Stock-Based Compensation | 32.4 M |
| Change in Working Capital | 0 |
| Others | -39 M |
| Free Cash Flow | 203 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | 69.2 | 48.2 | (25.0) | 71.5 | 26.8 | (22.7) | (39.1) | (74.9) | (94.2) | (27.3) | (17.9) | (16.2) |
| Depreciation & Amortization | 169.2 | 149.3 | 138.9 | 68.9 | 61.5 | 15.5 | 110.9 | 0.6 | 0.7 | 0.2 | 0.2 | 0.2 |
| Deferred Income Tax | (26.8) | (2.2) | (8.4) | (78.0) | 0 | 0 | 0 | 1.8 | 0 | 0 | 0 | 79 K |
| Stock Based Compensation | 32.4 | 27.1 | 22.9 | 24.3 | 21.9 | 16.5 | 13.8 | 7.9 | 5.8 | 2.2 | 22 K | 62 K |
| Other Operating Activities | (39.0) | 30.6 | 8.5 | 3.4 | 9.0 | 0.3 | 19.3 | 34 K | 34 K | 28 K | 20 K | 9 K |
| Change in Working Capital | 0 | 21.7 | (12.7) | 13.5 | (25.3) | 18.2 | 64.6 | (2.5) | 12.7 | 3.3 | (0.2) | (0.6) |
| Cash From Operations | 205.0 | 274.7 | 124.2 | 103.6 | 93.9 | 27.8 | 169.4 | (67.0) | (75.1) | (21.6) | (17.9) | (16.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (1.7) | (0.5) | (1.6) | (1.9) | (373.8) | (6.4) | (24.4) | (1.0) | (3.0) | (0.4) | 8 K | (0.2) |
| Other Items | (286.1) | (70.4) | (572.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (287.8) | (70.8) | (573.7) | (1.9) | (373.8) | (6.4) | (24.4) | (1.0) | (3.0) | (0.4) | 8 K | (0.2) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | (60.0) | (75.0) | (14.1) | (47.9) | (2.3) | (0.8) | (0.6) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 7.5 | (65.9) | 442.7 | (50.0) | 281.4 | 0 | 10.0 | (2.7) | (2.7) | (1.3) | 12.0 | 0.4 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (24.6) | (24.6) | 0 | 0 |
| Other Financing Activities | (8.1) | 0.7 | 8.1 | 8.6 | 5.1 | 2.0 | (127.2) | 1.8 | 0.9 | 69.9 | 72 K | 12.0 |
| Cash From Financing Activities | (60.6) | (140.2) | 436.7 | (89.3) | 286.5 | 2.0 | (117.2) | 33.5 | 135.6 | 116.0 | 12.0 | 12.4 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (143.4) | 63.8 | (12.7) | 12.3 | 6.6 | 23.4 | 27.8 | (34.5) | 57.5 | 94.1 | (5.9) | (4.4) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | 203.3 | 274.3 | 122.6 | 101.6 | (279.8) | 21.3 | 145.0 | (68.0) | (78.0) | (21.9) | (18.0) | (16.7) |